Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia

Research output: Contribution to journalLetter

49 Citations (Scopus)
Original languageEnglish
Pages (from-to)179-182
JournalLeukemia
Volume28
Issue number1
DOIs
Publication statusPublished - Jan 2014

Cite this